Deep learning and cancer biomarkers: recognising lead-time bias - Authors' reply

Lancet. 2021 Jan 16;397(10270):194-195. doi: 10.1016/S0140-6736(21)00035-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bias
  • Biomarkers, Tumor
  • Deep Learning*
  • Humans
  • Neoplasms* / diagnosis

Substances

  • Biomarkers, Tumor